Clinical Trial Detail

NCT ID NCT01591421
Title P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Patients With Metastatic or Advanced RAS-Wild Type Colorectal Cancer.
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NCIC Clinical Trials Group

colorectal cancer


Buparlisib + Panitumumab

Age Groups: adult

No variant requirements are available.